Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID S MILLER

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1568429934
CMS profile
343635
Location
DALLAS, TX

General Payments · PY2018–2024

$148,517.97

  • Reported across 316 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$13,668.12

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $8,965.00 5
Honoraria $2,655.00 1
Food and Beverage $2,048.12 24

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $4,928.58 10
EISAI INC. $2,703.55 4
Aadi Bioscience, Inc. $2,655.00 1
Acerta Pharma LLC $2,049.95 8
Merck Sharp & Dohme Corporation $750.00 1
Genmab U.S., Inc. $203.92 3
Myriad Genetic Laboratories, Inc. $150.28 1
ABBVIE INC. $116.03 1
ImmunoGen, Inc. $110.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $55,337.34 116
PY2019 $24,556.72 81
PY2020 $17,641.44 18
PY2021 $21,965.75 29
PY2022 $1,897.88 17
PY2023 $13,450.72 25
PY2024 $13,668.12 30

Payment records · PY2024 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aadi Bioscience, Inc. $2,655.00 06/01/2024 Honoraria Undisputed 01/23/2026 1119596605 CMS
ABBVIE INC. $116.03 09/18/2024 Food and Beverage Undisputed 01/23/2026 1105036027 CMS
AstraZeneca Pharmaceuticals LP $53.66 04/02/2024 Food and Beverage Undisputed 01/23/2026 1104299204 CMS
AstraZeneca Pharmaceuticals LP $116.61 04/02/2024 Food and Beverage Undisputed 01/23/2026 1104687372 CMS
AstraZeneca Pharmaceuticals LP $1,370.00 04/23/2024 Consulting Fee Undisputed 01/23/2026 1104197219 CMS
AstraZeneca Pharmaceuticals LP $22.10 06/15/2024 Food and Beverage Undisputed 01/23/2026 1105619509 CMS
AstraZeneca Pharmaceuticals LP $121.22 07/09/2024 Food and Beverage Undisputed 01/23/2026 1104666777 CMS
AstraZeneca Pharmaceuticals LP $137.45 08/22/2024 Food and Beverage Undisputed 01/23/2026 1104509866 CMS
AstraZeneca Pharmaceuticals LP $110.55 09/04/2024 Food and Beverage Undisputed 01/23/2026 1104538426 CMS
AstraZeneca Pharmaceuticals LP $118.36 09/04/2024 Food and Beverage Undisputed 01/23/2026 1105612545 CMS
Eisai Inc. $81.56 01/16/2024 Food and Beverage Undisputed 01/23/2026 1110740325 CMS
Eisai Inc. $2,445.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1110740329 CMS
Eisai Inc. $79.57 09/06/2024 Food and Beverage Undisputed 01/23/2026 1110740323 CMS
Eisai Inc. $97.42 10/15/2024 Food and Beverage Undisputed 01/23/2026 1110740327 CMS
Genmab U.S., Inc. $35.78 03/16/2024 Food and Beverage Undisputed 01/23/2026 1126825819 CMS
Genmab U.S., Inc. $139.21 06/12/2024 Food and Beverage Undisputed 01/23/2026 1126825821 CMS
Genmab U.S., Inc. $28.93 10/18/2024 Food and Beverage Undisputed 01/23/2026 1126825823 CMS
GlaxoSmithKline, LLC. $1,600.00 01/18/2024 Consulting Fee Undisputed 01/23/2026 1116591259 CMS
GlaxoSmithKline, LLC. $20.42 02/27/2024 Food and Beverage Undisputed 01/23/2026 1116592190 CMS
GlaxoSmithKline, LLC. $119.46 05/23/2024 Food and Beverage Undisputed 01/23/2026 1116294049 CMS
GlaxoSmithKline, LLC. $73.09 06/14/2024 Food and Beverage Undisputed 01/23/2026 1116297770 CMS
GlaxoSmithKline, LLC. $62.56 08/23/2024 Food and Beverage Undisputed 01/23/2026 1116535320 CMS
GlaxoSmithKline, LLC. $120.61 10/02/2024 Food and Beverage Undisputed 01/23/2026 1116204426 CMS
GlaxoSmithKline, LLC. $16.84 10/08/2024 Food and Beverage Undisputed 01/23/2026 1115811889 CMS
GlaxoSmithKline, LLC. $3.19 10/08/2024 Food and Beverage Undisputed 01/23/2026 1116019430 CMS
GlaxoSmithKline, LLC. $112.41 12/04/2024 Food and Beverage Undisputed 01/23/2026 1116486695 CMS
GlaxoSmithKline, LLC. $2,800.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 1116348298 CMS
ImmunoGen, Inc. $110.81 01/30/2024 Food and Beverage Undisputed 01/23/2026 1099941701 CMS
Merck Sharp & Dohme LLC $750.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1141552314 CMS
Myriad Genetic Laboratories, Inc. $150.28 05/15/2024 Food and Beverage Undisputed 01/23/2026 1152536397 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.